Report Detail
Global Human Rotavirus Vaccine Market Insights, Forecast to 2025
- RnM2359026 |
- 14 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
The global Human Rotavirus Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Rotavirus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Human Rotavirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Rotavirus Vaccine in these regions.
This research report categorizes the global Human Rotavirus Vaccine market by top players/brands, region, type and end user. This report also studies the global Human Rotavirus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bharat Biotech
Merck
GlaxoSmithKline
Market size by Product
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market size by End User
Hospitals & Clinics
Academic And Research
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Human Rotavirus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Rotavirus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Rotavirus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Rotavirus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Human Rotavirus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Rotavirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Human Rotavirus Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Product
- 1.4.2 Rotarix
- 1.4.3 RotaTeq
- 1.4.4 Rotavac
- 1.4.5 Rotavin-M1
- 1.4.6 Lanzhou lamb
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Human Rotavirus Vaccine Market Size Growth Rate by End User
- 1.5.2 Hospitals & Clinics
- 1.5.3 Academic And Research
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Rotavirus Vaccine Market Size
- 2.1.1 Global Human Rotavirus Vaccine Revenue 2014-2025
- 2.1.2 Global Human Rotavirus Vaccine Sales 2014-2025
- 2.2 Human Rotavirus Vaccine Growth Rate by Regions
- 2.2.1 Global Human Rotavirus Vaccine Sales by Regions
- 2.2.2 Global Human Rotavirus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Human Rotavirus Vaccine Sales by Manufacturers
- 3.1.1 Human Rotavirus Vaccine Sales by Manufacturers
- 3.1.2 Human Rotavirus Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Human Rotavirus Vaccine Revenue by Manufacturers
- 3.2.1 Human Rotavirus Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Rotavirus Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Human Rotavirus Vaccine Price by Manufacturers
- 3.4 Human Rotavirus Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Rotavirus Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Human Rotavirus Vaccine Sales by Product
- 4.2 Global Human Rotavirus Vaccine Revenue by Product
- 4.3 Human Rotavirus Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Human Rotavirus Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Human Rotavirus Vaccine by Countries
- 6.1.1 North America Human Rotavirus Vaccine Sales by Countries
- 6.1.2 North America Human Rotavirus Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Human Rotavirus Vaccine by Product
- 6.3 North America Human Rotavirus Vaccine by End User
7 Europe
- 7.1 Europe Human Rotavirus Vaccine by Countries
- 7.1.1 Europe Human Rotavirus Vaccine Sales by Countries
- 7.1.2 Europe Human Rotavirus Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Human Rotavirus Vaccine by Product
- 7.3 Europe Human Rotavirus Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Human Rotavirus Vaccine by Countries
- 8.1.1 Asia Pacific Human Rotavirus Vaccine Sales by Countries
- 8.1.2 Asia Pacific Human Rotavirus Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Human Rotavirus Vaccine by Product
- 8.3 Asia Pacific Human Rotavirus Vaccine by End User
9 Central & South America
- 9.1 Central & South America Human Rotavirus Vaccine by Countries
- 9.1.1 Central & South America Human Rotavirus Vaccine Sales by Countries
- 9.1.2 Central & South America Human Rotavirus Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Human Rotavirus Vaccine by Product
- 9.3 Central & South America Human Rotavirus Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Human Rotavirus Vaccine by Countries
- 10.1.1 Middle East and Africa Human Rotavirus Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Human Rotavirus Vaccine by Product
- 10.3 Middle East and Africa Human Rotavirus Vaccine by End User
11 Company Profiles
- 11.1 Bharat Biotech
- 11.1.1 Bharat Biotech Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
- 11.1.5 Bharat Biotech Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Human Rotavirus Vaccine Products Offered
- 11.2.5 Merck Recent Development
- 11.3 GlaxoSmithKline
- 11.3.1 GlaxoSmithKline Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
- 11.3.5 GlaxoSmithKline Recent Development
12 Future Forecast
- 12.1 Human Rotavirus Vaccine Market Forecast by Regions
- 12.1.1 Global Human Rotavirus Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Human Rotavirus Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Human Rotavirus Vaccine Market Forecast by Product
- 12.2.1 Global Human Rotavirus Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Human Rotavirus Vaccine Market Forecast by End User
- 12.4 North America Human Rotavirus Vaccine Forecast
- 12.5 Europe Human Rotavirus Vaccine Forecast
- 12.6 Asia Pacific Human Rotavirus Vaccine Forecast
- 12.7 Central & South America Human Rotavirus Vaccine Forecast
- 12.8 Middle East and Africa Human Rotavirus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Rotavirus Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Rotavirus Vaccine . Industry analysis & Market Report on Human Rotavirus Vaccine is a syndicated market report, published as Global Human Rotavirus Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Rotavirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
